Table 4.

Multivariable Logistic Regression Analysis on CPA, In-Hospital Mortality, and Bleeding Complications in the Younger Group

	CPA			In-Hospital Mortality			Bleeding Complications
	OR	95% CI	P Value	OR	95% CI	P Value	OR	95% CI	P Value
Age, y
40-49 (reference)	1.000			1.000			1.000
20-29	0.849	0.510-1.413	0.53	0.622	0.137-2.813	0.54	not applicable	not applicable	not applicable
30-39	1.045	0.896-1.220	0.57	0.850	0.487-1.484	0.57	0.552	0.145-2.104	0.38
Male	1.008	0.838-1.212	0.93	0.782	0.440-1.390	0.40	0.364	0.143-0.922	0.03
Hypertension	0.627	0.560-0.703	<0.001	0.768	0.522-1.129	0.18	1.222	0.537-2.783	0.63
Diabetes	1.014	0.897-1.147	0.82	1.903	1.299-2.789	<0.001	0.954	0.403-2.259	0.92
Dyslipidemia	0.485	0.433-0.543	<0.001	0.535	0.363-0.787	0.002	0.544	0.238-1.240	0.15
Smoking	0.737	0.660-0.824	<0.001	0.787	0.548-1.131	0.20	0.587	0.273-1.264	0.17
Chronic kidney disease	2.484	2.063-2.991	<0.001	2.190	1.344-3.569	0.002	1.245	0.423-3.668	0.69
History of heart failure	1.974	1.509-2.582	<0.001	0.999	0.462-2.162	1.00	4.940	1.541-15.833	0.007
History of MI	0.521	0.419-0.648	<0.001	1.002	0.537-1.871	0.99	1.160	0.327-4.117	0.82
Multivessel disease	1.176	1.042-1.328	0.008	1.582	1.063-2.357	0.02	0.601	0.232-1.562	0.30
LMT lesions	6.171	4.878-7.807	<0.001	6.748	3.854-11.815	<0.001	2.601	0.880-7.686	0.08
STEMI				0.500	0.341-0.735	<0.001	0.719	0.313-1.653	0.44
CPA				14.21	9.201-21.949	<0.001	9.560	3.730-24.503	<0.001
Acute heart failure				2.402	1.570-3.674	<0.001	1.299	0.525-3.215	0.57
Antiplatelet therapy				0.795	0.529-1.195	0.27	0.467	0.205-1.063	0.07
Oral anticoagulants				1.333	0.445-3.995	0.61	0.508	0.0355-7.269	0.62
Radial approach				0.277	0.174-0.441	<0.001	0.338	0.125-0.915	0.03

Abbreviations as in Tables 1 and 2.